171
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A pathogenic variant in SLC26A4 is associated with Pendred syndrome in a consanguineous Iranian family

, , , , , , , & show all
Pages 628-634 | Received 30 Aug 2017, Accepted 09 May 2019, Published online: 12 Jun 2019
 

Abstract

Objective: Hearing loss (HL) is a common sensory deficit with high phenotypic and genotypic heterogeneity. A large Iranian family with HL was genetically assessed in this study.

Design: A proband from a consanguineous multiplex HL family from Iran was examined via Targeted Next-Generation Sequencing (TNGS). Sanger sequencing allowed the segregation analysis of the variant of interest and the investigation of its presence in a cohort of 50 ethnicity-matched healthy control individuals. The gene was previously associated with HL. Therefore, to determine whether the variant was specifically associated with Pendred Syndrome (PDS) or DFNB4, biochemical analyses, PTA, thyroid scans by Tc99m, perchlorate discharge test and high-resolution CT scan of the temporal bone were carried out on the affected family members.

Study sample: Ten members of a large multiplex Iranian family with HL were recruited in this study. In addition, 50 unrelated healthy controls of the same ethnic group were randomly selected to genotype the variant.

Results: A homozygous missense variant (NM_000441.1: c.1211C > T/p.Thr404Ile) in exon 10 was found segregating in the family. Based on the ACMG’s guidelines, the variant was classified as pathogenic.

Conclusion: This study expands the spectrum of SLC26A4 pathogenic variants in hearing loss.

Acknowledgements

Hereby, we would like to express our special thanks to our patients for their collaboration.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The project was supported by deputies of research of Shahrekord University of Medical Sciences [1600, 1497], Isfahan University of Medical Sciences [194068], and Ahvaz Jundishapur University of Medical Sciences [U-91074].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.